Top

European Archives of Oto-Rhino-Laryngology

Published in:

01-05-2017 | Review Article

The role of bone resorption in the etiopathogenesis of acquired middle ear cholesteatoma

Authors: Shumin Xie, Xiaoli Wang, Jihao Ren, Wei Liu

Published in: European Archives of Oto-Rhino-Laryngology | Issue 5/2017

Abstract

Cholesteatoma is a destructive squamous epithelial lesion of the temporal bone which gradually expands and leads to serious complications by destruction of nearby bony structures. Erosion caused by bone resorption of the ossicular chain and bony labyrinth may result in hearing loss, vestibular dysfunction, facial paralysis, labyrinthine fistulae and intracranial complications. The exact underlying cellular and molecular mechanism of bone resorption in acquired cholesteatoma still remains unexplained. Pubmed database and China National Knowledge Infrastructure were screened for articles focusing on bone resorption in acquired cholesteatoma. Osteoclast activation, pressure necrosis, acid lysis, enzyme mediation, inflammatory mediators and several newly discovered biomolecules are outlined as main theories behind bone resorption in acquired cholesteatoma, aiming to facilitate the development of potential therapeutic targets for preventing intracranial and extracranial complications caused by bone resorption in acquired middle ear cholesteatoma.

Maniu A, Harabaqiu O, Perde Schrepler M, Cǎtanǎ A, Fǎnutǎ B, Mogoantǎ CA (2014) Molecular biology of cholesteatoma. Rom J Morphol Embryol 55:7–13PubMed

Louw L (2013) Acquired cholesteatoma: summary of the cascade of molecular events. J Laryngol Otol 127:542–549CrossRefPubMed

Zhu Z, Hong Y, Wang Y, He G, Ye S (2016) The significance of keratinocyte in hyperproliferation of middle ear cholesteatoma. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 30:139–143PubMed

Fukudome S, Wang C, Hamajima Y, Ye S, Zheng Y, Narita N, Sunaga H, Fujieda S, Hu X, Feng L, Lin J (2013) Regulation of the angiogenesis of acquired middle ear cholesteatomas by inhibitor of DNA binding transcription factor. JAMA Otolaryngol Head Neck Surg 139:273–278CrossRefPubMed

Zhang QA, Hamajima Y, Zhang Q, Lin J (2008) Identification of Id1 in acquired middle ear cholesteatoma. Arch Otolaryngol Head Neck Surg 134:306–310CrossRefPubMedPubMedCentral

Hamajima Y, Komori M, Preciado DA, Choo DI, Moribe K, Murakami S, Ondrey FG, Lin J (2010) The role of inhibitor DNA-binding (Id1) in hyperproliferation of keratinocytes: the pathological basis for middle ear cholesteatoma from chronic otitis media. Cell Prolif 43:457–463CrossRefPubMedPubMedCentral

Hamzei M, Ventriglia G, Hagnia M, Antonopolous A, Bernal-Sprekelsen M, Dazert S, Hildmann H, Sudhoff H (2003) Osteoclast stimulating and differentiating factors in human cholesteatoma. Laryngoscope 113:436–442CrossRefPubMed

Si Y, Chen YB, Chen SJ, Zheng YQ, Liu X, Liu Y, Jiang HL, Xu G, Li ZH, Huang QH, Xiong H, Zhang ZG (2015) TLR4 drives the pathogenesis of acquired cholesteatoma by promoting local inflammation and bone destruction. Sci Rep 5:16683. doi:10.1038/srep16683 CrossRefPubMedPubMedCentral

Nason R, Jung JY, Chole RA (2009) Lipopolysaccharide-induced osteoclastogenesis from mononuclear precursors: a mechanism for osteolysis in chronic otitis. J Assoc Res Otolaryngol 10:151–160CrossRefPubMedPubMedCentral

10.

Sudhoff H, Liebehenz Y, Aschenbrenner J, Jung J, Hildmann H, Dazert S (2003) A murine model of cholesteatoma-induced bone resorption using autologous dermal implantation. Laryngoscope 113:1022–1026CrossRefPubMed

11.

Sabokbar A, Mahoney DJ, Hemingway F, Athanasou NA (2015) Non-canonical (RANKL-independent) pathways of osteoclast differentiation and their role in musculoskeletal diseases. Clin Rev Allergy Immunol 51:16–26CrossRef

12.

Iwamoto Y, Nishikawa K, Imai R, Furuya M, Uenaka M, Ohta Y, Morihana T, Itoi-Ochi S, Penninger JM, Katayama I, Inohara H, Ishii M (2016) Intercellular communication between keratinocytes and fibroblasts induces local osteoclast differentiation: a mechanism underlying cholesteatoma-induced bone destruction. Mol Cell Biol 36:1610–1620CrossRefPubMedPubMedCentral

13.

Kuczkowski J, Kobierska-Gulida G, Izycka-Swieszewska E, Potocka M, Mikaszewski B, Sierszeń W (2010) Molecular control of bone resorption in chronic otitis media with cholesteatoma. Otolaryngol Pol 64:219–224CrossRefPubMed

14.

Chen AP, Wang B, Zhong F, Song GZ, Song HF, Yu K, Wang HB, Jiang ZH (2015) Expression levels of receptor activator of nuclear factor-κB ligand and osteoprotegerin are associated with middle ear cholesteatoma risk. Acta Otolaryngol 135:655–666CrossRefPubMed

15.

Jeong JH, Park CW, Tae K, Lee SH, Shin DH, Kim KR, Park YW (2006) Expression of RANKL and OPG in middle ear cholesteatoma tissue. Laryngoscope 116:1180–1184CrossRefPubMed

16.

Kuczkowski J, Sakowicz-Burkiewicz M, Iżycka-Świeszewska E (2010) Expression of the receptor activator for nuclear factor-kappaB ligand and osteoprotegerin in chronic otitis media. Am J Otolaryngol 31:404–409CrossRefPubMed

17.

Ma Y, Ye S (2008) The expression of receptor activator nuclear factor-κB ligand and osteoprotegerin in cholesteatoma. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 22:293–295PubMed

18.

Abramson M, Moriyama H, Huang CC (1984) Pathogenic factors in bone resorption in cholesteatoma. Acta Otolaryngol 97:437–442CrossRefPubMed

19.

Abramson M, Moriyama H, Huang CC (1984) Histology, pathogenesis, and treatment of cholesteatoma. Ann Otol Rhinol Laryngol Suppl 112:125–128CrossRefPubMed

20.

Macri JR, Chole RA (1985) Bone erosion in experimental cholesteatoma—the effects of implanted barriers. Otolaryngol Head Neck Surg 93:3–17PubMed

21.

Chole RA, McGinn MD, Tinling SP (1985) Pressure-induced bone resorption in the middle ear. Ann Otol Rhinol Laryngol 94:165–170CrossRefPubMed

22.

Wolfman DE, Chole RA (1986) Osteoclast stimulation by positive middle-ear air pressure. Arch Otolaryngol Head Neck Surg 112:1037–1042CrossRefPubMed

23.

Orisek BS, Chole RA (1987) Pressures exerted by experimental cholesteatomas. Arch Otolaryngol Head Neck Surg 113:386–391CrossRefPubMed

24.

Huang CC, Yi ZX, Yuan QG, Abramson M (1990) A morphometric study of the effects of pressure on bone resorption in the middle ear of rats. Am J Otol 11:39–43PubMed

25.

Burger EH, Klein-Nulen J (1999) Responses of bone cells to biomechanical forces in vitro. Adv Dent Res 13:93–98CrossRefPubMed

26.

Walsh TE, Covell WP, Ogura JH (1951) The effect of cholesteatosis on bone. Ann Otol Rhinol Laryngol 60:1100–1113CrossRefPubMed

27.

Iino Y, Hoshino E, Tomioka S, Takasaka T, Kaneko Y, Yuasa R (1983) Organic acid and anaerobic microorganisms in the contents of the cholesteatoma sac. Ann Otol Rhinol Laryngol 92:91–96CrossRefPubMed

28.

Nguyen KH, Suzuki H, Ohbuchi T, Wakasugi T, Koizumi H, Hashida K, Baba R, Morimoto H, Doi Y (2014) Possible participation of acidic pH in bone resorption in middle ear cholesteatoma. Laryngoscope 124:245–250CrossRefPubMed

29.

Chen ZF, Darvell BW, Leung VW (2004) Hydroxyapatite solubility in simple inorganic solutions. Arch Oral Biol 49:359–367CrossRefPubMed

30.

Chan A, Mauro T (2011) Acidification in the epidermis and the role of secretor phospholipases. Dermatoendocrinol 3:84–90CrossRefPubMedPubMedCentral

31.

Koizumi H, Suzuki H, Ohbuchi T, Kitamura T, Hashida K, Nakamura M (2015) Increased permeability of the epithelium of middle ear cholesteatoma. Clin Otolaryngol 40:106–114CrossRefPubMed

32.

Xie S, Xiang Y, Wang X, Ren H, Yin T, Ren J, Liu W (2016) Acquired cholesteatoma epithelial hyperproliferation: roles of cell proliferation signal pathways. Laryngoscope 126:1923–1930CrossRefPubMed

33.

Clarke MV, Russell RK, Findlay DM, Sastra S, Anderson PH, Skinner JP, Atkins GJ, Zajac JD, Davey RA (2015) A role for the calcitonin receptor to limit bone loss during lactation in female mice by inhibiting osteocytic osteolysis. Endocrinology 156:3203–3214CrossRefPubMed

34.

Wang HB, Xu ZW, Tang AZ, Su JP (2004) Expression of carbonic anhydrase in the cholesteatoma epithelium (in Chinese). J Clin Otorhinolaryngol 18:241–242

35.

Nabai L, Kilani RT, Aminuddin F, Li Y, Ghahary A (2015) Methotrexate modulates the expression of MMP-1 and type 1 collagen in dermal fibroblast. Mol Cell Biochem 409:213–224CrossRefPubMed

36.

Kobayashi T (2014) MMP-2, -9 and TIMP-1, -2 assays in keratinocyte cultures. Methods Mol Biol 1195:145–155CrossRefPubMed

37.

Rezende CE, Souto RP, Rapoport PB, Campos Ld, Generato MB (2012) Cholesteatoma gene expression of matrix metalloproteinases and their inhibitors by RT-PCR. Braz J Otorhinolaryngol 78:116–121CrossRefPubMed

38.

Olszewska E, Matulka M, Mroczko B, Pryczynicz A, Kemona A, Szmitkowski M, Mierzwinski J, Pietrewicz T (2016) Diagnostic value of matrix metalloproteinase 9 and tissue inhibitor of matrix metalloproteinases 1 in cholesteatoma. Histol Histopathol 31:307–315PubMed

39.

Juhász A, Sziklai I, Rákosy Z, Ecsedi S, Adány R, Balázs M (2009) Elevated level of tenascin and matrix metalloproteinase 9 correlates with the bone destruction capacity of cholesteatoma. Otol Neurotol 30:559–565CrossRefPubMed

40.

Suchozebrska-Jesionek D, Szymański M, Kurzepa J, Golabek W, Stryjecka-Zimmer M (2008) Gelatinolytic activity of matrix metalloproteinases 2 and 9 in middle ear cholesteatoma. J Otolaryngol Head Neck Surg 37:628–632PubMed

41.

Liu J, Lin G, Huang J, Jiang Z (2002) The expression of matrix metalloproteinase-1 and interleukin-1-alpha messenger ribonucleic acid in human middle ear cholesteatoma. Zhonghua Er Bi Yan Hou Ke Za Zhi 37:30–33PubMed

42.

Mehta D, Daudia A, Birchall JR, Banerjee AR (2007) The localization of matrix metalloproteinases-8 and -13 in cholesteatoma, deep-meatal and post-auricular skin: a comparative analysis. Acta Otolaryngol 127:138–142CrossRefPubMed

43.

Meephansan J, Komine M, Tsuda H, Ohtsuki M (2012) Suppressive effect of calcipotriol on the induction of matrix metalloproteinase (MMP)-9 and MMP-13 in a human squamous cell carcinoma cell line. Clin Exp Dermatol 37:889–896CrossRefPubMed

44.

Halder SK, Osteen KG, Al-Hendy A (2013) Vitamin D3 inhibits expression and activities of matrix metalloproteinase-2 and -9 in human uterine fibroid cells. Hum Reprod 28:2407–2416CrossRefPubMedPubMedCentral

45.

Kobayashi H, Asano K, Kanai K, Suzaki H (2005) Suppressive activity of vitamin D3 on matrix metalloproteinase production from cholesteatoma keratinocytes in vitro. Mediators Inflamm 2005:210–215CrossRefPubMedPubMedCentral

46.

Schönermark MP, Issing PR, Erbrich BK, Lenarz T (1999) Expression pattern of the plasminogen activator-plasmin system in human cholesteatoma. Ann Otol Rhinol Laryngol 108:245–252CrossRefPubMed

47.

Celebi O, Paksoy M, Aydin S, Sanli A, Tasdemir O, GüL AE (2010) Myeloperoxydase activity in the pathogenesis of cholesteatoma. Indian J Otolaryngol Head Neck Surg 62:32–35CrossRefPubMedPubMedCentral

48.

Jung JY, Pashia ME, Nishimoto SY, Faddis BT, Chole RA (2004) A possible role for nitric oxide in osteoclastogenesis associated with cholesteatoma. Otol Neurotol 25:661–668CrossRefPubMed

49.

Jung JY, Lin AC, Ramos LM, Faddis BT, Chole RA (2003) Nitric oxide synthase I mediates osteoclast activity in vitro and in vivo. J Cell Biochem 89:613–621CrossRefPubMed

50.

Olszewska E, Olszewski S, Borzym-Kluczyk M, Zwierz K (2007) Role of N-acetyl-β-d-hexosaminidase in cholesteatoma tissue. Acta Biochim Pol 54:365–370PubMed

51.

Olszewska E, Jakimowicz-Rudy J, Knas M, Chilimoniuk M, Pietruski JK, Sieskiewicz A (2012) Cholesteatoma-associated pathogenicity: potential role of lysosomal exolglycosidases. Otol Neurotol 33:596–603CrossRefPubMed

52.

Likus W, Siemianowicz K, Markowski J, Wiaderkiewicz J, Kostrząb-Zdebel A, Jura-Szołtys E, Dziubdziela W, Wiaderkiewicz R, Łos MJ (2016) Bacterial infections and osteoclastogenesis regulators in men and women with cholesteatoma. Arch Immunol Ther Exp (Warsz) 64:241–247CrossRef

53.

Vitale RF, Ribeiro Fde A (2007) The role of tumor necrosis factor-alpha (TNF-α) in bone resorption present in middle ear cholesteatoma. Braz J Otorhinolaryngol 73:117–121CrossRefPubMed

54.

Kuczkowski J, Sakowicz-Burkiewicz M, Iżycka-Świeszewska E, Mikaszewski B, Pawelczyk T (2011) Expression of tumor necrosis factor-α, interleukin-1α, interleukin-6 and interleukin-10 in chronic otitis media with bone osteolysis. ORL J Otorhinolaryngol Relat Spec 73:93–99CrossRefPubMed

55.

Haynes DR (2004) Bone lysis and inflammation. Inflamm Res 53:596–600CrossRefPubMed

56.

Peng L, Zhang H, Zhou Y, Li W, Jiang P, Zhang Y, Song K (2015) TNF-α suppression and osteoprotegerin overexpression inhibits wear debris-induced inflammation and osteoclastogenesis in vitro. Int J Artif Organs 38:565–571CrossRefPubMed

57.

Haruyama T, Furukawa M, Kusunoki T, Onoda J, Ikeda K (2010) Expression of IL-17 and its role in bone destruction in human middle ear cholesteatoma. ORL J Otorhinolaryngol Relat Spec 72:325–331CrossRefPubMed

58.

Wu M, Peng A, Sun M, Deng Q, Hazlett LD, Yuan J, Liu X, Gao Q, Feng L, He J, Zhang P, Huang X (2011) TREM-1 amplifies corneal inflammation after Pseudomonas aeruginosa infection by modulating Toll-like receptor signaling and Th1/Th2-type immune responses. Infect Immun 79:2709–2716CrossRefPubMedPubMedCentral

59.

Szczepański M, Szyfter W, Jenek R, Wróbel M, Lisewska IM, Zeromski J (2006) Toll-like receptors 2, 3 and 4 (TLR-2, TLR-3 and TLR-4) are expressed in the microenvironment of human acquired cholesteatoma. Eur Arch Otorhinolaryngol 263:603–607CrossRefPubMed

60.

Hirai H, Kariya S, Okano M, Fukushima K, Kataoka Y, Maeda Y, Nishizaki K (2013) Expression of toll-like receptors in chronic otitis media and cholesteatoma. Int J Pediatr Otorhinolaryngol 77:674–676CrossRefPubMed

61.

Chi Z, Wang Z, Liang Q, Zhu Y, Du Q (2015) Induction of cytokine production in cholesteatoma keratinocytes by extracellular high-mobility group box chromosomal protein 1 combined with DNA released by apoptotic cholesteatoma keratinocytes. Mol Cell Biochem 400:189–200CrossRefPubMed

62.

Zong JC, Wang X, Zhou X, Wang C, Chen L, Yin LJ, He BC, Deng ZL (2016) Gut-derived serotonin induced by depression promotes breast cancer bone metastasis through the RUNX2/PTHrP/RANKL pathway in mice. Oncol Rep 35:739–748PubMed

63.

Horiuchi T, Yoshida T, Koshihara Y, Sakamoto H, Kanai H, Yamamoto S, Ito H (1999) The increase of parathyroid hormone-related peptide and cytokine levels in synovial fluid of elderly rheumatoid arthritis and osteoarthritis. Endocr J 46:643–649CrossRefPubMed

64.

Foley J, Nickerson N, Riese DJ 2nd, Hollenhorst PC, Lorch G, Foley AM (2012) At the crossroads: EGFR and PTHrP signaling in cancer-mediated diseases of bone. Odontology 100:109–129CrossRefPubMedPubMedCentral

65.

Cafforio P, Savonarola A, Stucci S, De Matteo M, Tucci M, Brunetti AE, Vecchio VM, Silvestris F (2014) PTHrP produced by myeloma plasma cells regulates their survival and pro-osteoclast activity for bone disease progression. J Bone Miner Res 29:55–66CrossRefPubMed

66.

Cheshire IM, Blight A, Ratcliffe WA, Proops DW, Heath DA (1991) Production of parathyroid-hormone-related protein by cholesteatoma cells in culture. Lancet 338:1041–1043CrossRefPubMed

67.

Cheshire IM, Blight A, Ratcliffe WA, Proops DW (1995) In vitro production of parathyroid hormone-related protein by cholesteatoma and normal skin. Clin Otolaryngol Allied Sci 20:448–452CrossRefPubMed

68.

Liang Z, Wang Y, Shen Z, Teng X, Li X, Li C, Wu W, Zhou Z, Wang Z (2016) Fascin 1 promoted the growth and migration of non-small cell lung cancer cells by activating YAP/TEAD signaling. Tumour Biol 37:10909–10915CrossRefPubMed

69.

Min KW, Chae SW, Kim DH, Do SI, Kim K, Lee HJ, Sohn JH, Pyo JS, Kim DH, Oh S, Choi SH, Park YL, Park CH (2015) Fascin expression predicts an aggressive clinical course in patients with advanced breast cancer. Oncol Lett 10:121–130PubMedPubMedCentral

70.

Binnetoglu A, Sari M, Baglam T, Erbarut Seven I, Yumusakhuylu AC, Topuz MF, Batman C (2015) Fascin expression in cholesteatoma: correlation with destruction of the ossicular chain and extent of disease. Clin Otolaryngol 40:335–340CrossRefPubMed

71.

Oger M, Alpay HC, Orhan I, Onalan EE, Yanilmaz M, Sapmaz E (2013) The effect of BMP-2, BMP-4 and BMP-6 on bone destruction of cholesteatoma presence. Am J Otolaryngol 34:652–657CrossRefPubMed

Title: The role of bone resorption in the etiopathogenesis of acquired middle ear cholesteatoma
Authors: Shumin Xie
Xiaoli Wang
Jihao Ren
Wei Liu
Publication date: 01-05-2017
Publisher: Springer Berlin Heidelberg
Published in: European Archives of Oto-Rhino-Laryngology / Issue 5/2017
Print ISSN: 0937-4477
Electronic ISSN: 1434-4726
DOI: https://doi.org/10.1007/s00405-016-4422-6

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

The role of bone resorption in the etiopathogenesis of acquired middle ear cholesteatoma

Abstract

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2017

Starplasty tracheostomy: case series and literature review

Post-tonsillectomy pain after using bipolar diathermy scissors or the harmonic scalpel: a randomised blinded study

Acoustic schwannoma with intracochlear extension and primary intracochlear schwannoma: removal through translabyrinthine approach with facial bridge cochleostomy and transcanal approach

First intraoperative experience with three-dimensional (3D) high-definition (HD) nasal endoscopy for lacrimal surgeries

Preferred nasolabial angle in Middle Eastern population

Benchmarking of venous thromboembolism prophylaxis practice with ENT.UK guidelines